Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Press releases
September 8, 2021
Eirion Therapeutics Announces Strategic Agreement
As part of the agreement, HTL will build, validate and operate a botulinum manufacturing facility in the US. In the future, HTL Biotechnology expects to apply to the CDC to have the facility certified to manufacture botulinum and later apply to the FDA to have it certified as a GMP plant.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Press releases June 5, 2025HTL Biotechnology inaugurates a new production line dedicated to sterile hyaluronic acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
-
Press releases May 27, 2025HTL Biotechnology supports National Biomedicines manufacturing Day
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.